Critical role for Env as well as Gag-Pol in control of a simian-human immunodeficiency virus 89.6P challenge by a DNA prime/recombinant modified vaccinia virus ankara vaccine

Journal of Virology

Volumn 76, Issue 12, 2002, Pages 6138-6146

  Amara, Rama Rao ^a   Smith, James M ^a   Staprans, Silvija I ^a   Montefiori, David C ^a   Villinger, Francois ^a   Altman, John D ^a   O'Neil, Shawn P ^a   Kozyr, Natalia L ^a   Xu, Yan ^a   Wyatt, Linda S ^a   Earl, Patricia L ^a   Herndon, James G ^a   McNicholl, Janet M ^a   McClure, Harold M ^a   Moss, Bernard ^a   Robinson, Harriet L ^a  

^a NONE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD4 ANTIGEN; EPITOPE; GAG PROTEIN; POL PROTEIN; RECOMBINANT VACCINE; VACCINIA VACCINE; VIRUS PROTEIN;

APOPTOSIS; ARTICLE; CELL PROTECTION; CELLULAR IMMUNITY; CONTROLLED STUDY; DNA RECOMBINATION; ENVELOPE GENE; GENE CONTROL; HUMAN IMMUNODEFICIENCY VIRUS; IMMUNE RESPONSE; MACACA; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; SIMIAN IMMUNODEFICIENCY VIRUS; T LYMPHOCYTE SUBPOPULATION; VIRUS ENVELOPE; VIRUS PATHOGENESIS;

AIDS VACCINES; ANIMALS; CD4-POSITIVE T-LYMPHOCYTES; FUSION PROTEINS, GAG-POL; GENE PRODUCTS, ENV; HIV; HIV ANTIBODIES; HIV INFECTIONS; HUMANS; MACACA MULATTA; SIMIAN ACQUIRED IMMUNODEFICIENCY SYNDROME; SIMIAN IMMUNODEFICIENCY VIRUS; VACCINATION; VACCINES, DNA; VACCINIA VIRUS;

EID: 0036113771     PISSN: 0022538X     EISSN: None     Source Type: Journal    
DOI: 10.1128/JVI.76.12.6138-6146.2002     Document Type: Article

References (23)

1. Induction of AIDS virus-specific CTL activity in fresh, unstimulated peripheral blood Jymphocytes from rhesus macaques vaccinated with a DNA prime/modified vaccinia virus Ankara boost regimen
2. Control of a mucosal challenge and prevention of AIDS by a multiprotein DNA/MVA vaccine
3. Crosslinking CD4 by human immunodeficiency virus gp120 primes T cells for activation-induced apoptosis
4. Reduction of simian-human immunodeficiency virus 89.6P viremia in rhesus monkeys by recombinant modified vaccinia virus Ankara vaccination
5. Control of viremia and prevention of clinical AIDS in rhesus monkeys by cytokine-augmented DNA vaccination
6. Quantification of latent tissue reservoirs and total body viral load in HIV-1 infection
7. + T-cell depletion in macaques infected by a simian-human immunodeficiency virus
8. Sensitive and robust one-tube real-time reverse transcriptase-polymerase chain reaction to quantify SIV RNA load: Comparison of one- versus two-enzyme systems
9. + lymphocyte depletion in rhesus monkeys
10. +-T-cell response to human cytomegalovirus: The 72-kilodalton major immediate-early protein revisited
11. *01 in the rhesus macaque detected by polymerase chain reaction with sequence-specific primers and direct sequencing
12. Use of overlapping peptide mixtures as antigens for cytokine flow cytometry
13. + T-cell depletion in HIV disease
14. Neutralizing antibodies in sera from macaques infected with chimeric simian-human immunodeficiency virus containing the envelope glycoproteins of either a laboratory-adapted variant or a primary isolate of human immunodeficiency virus type 1
15. Evaluation of antiviral drugs and neutralizing antibodies to human immunodeficiency virus by a rapid and sensitive microtiter infection assay
16. Recombinant modified vaccinia virus Ankara expressing the surface gp120 of simian immunodeficiency virus (SIV) primes for a rapid neutralizing antibody response to SIV infection in macaques
17. Role of immune responses against the envelope and the core antigens of simian immunodeficiency virus SIVmne in protection against homologous cloned and uncloned virus challenge in macaques
18. A valid ELISPOT assay for enumeration of ex vivo, antigenspecific, IFNγ-producing T cells
19. The prime-boost strategy: Exciting prospects for improved vaccination
20. An effective AIDS vaccine based on live attenuated vesicular stomatitis virus recombinants
21. + T cells using heterologous prime-boost immunisation strategies
22. Replication-incompetent adenoviral vaccine vector elicits effective anti-immunodeficiency virus immunity
23. Sensitization of T cells to CD95-mediated apoptosis by HIV-1 Tat and gp120